Characteristics | control group | remission group | active group |
---|---|---|---|
Age (Years), Mean ± SD | 31.15 ± 5.89 | 27.09 ± 6.59 | 27.54 ± 6.44 |
Gender, n (%) | |||
Male | 9(45.0%) | 17(53.1%) | 15(53.6%) |
Female | 11(55.0%) | 15(46.9%) | 13(46.4%) |
Course (Years), Mean ± SD | 3.65 ± 2.45 | 3.96 ± 2.44 | |
Location | |||
Ileum, n (%) | 2(6.2%) | 1(3.6%) | |
Ileocolon, n (%) | 18(56.3%) | 22(78.6%) | |
Colon, n(%) | 12(37.5%) | 5(17.8%) | |
Classification | |||
Penetrating, n(%) | 5(15.6%) | 7(25.0%) | |
Stricturing, n(%) | 21(65.6%) | 16(57.2%) | |
Non-stricturing & non-penetrating, n(%) | 6(18.8%) | 5(17.8%) | |
Perianally lesions, n(%) | 3(9.4%) | 6(21.4%) | |
Operation history, n(%) | 5(16.6%) | 9(32.1%) | |
Smoking history, n(%) | 2(10.0%) | 4(12.5%) | 6(21.4%) |
Best CDAI Score, Mean ± SD | 19.35 ± 10.97 | 102.09 ± 28.79 | 329.83 ± 108.69 |
SES-CD Score, Mean ± SD | 1.45 ± 0.94 | 15.07 ± 3.26 | 6.43 ± 1.68 |
MaRIA Score, Mean ± SD | 3.51 ± 1.86 | 12.14 ± 1.22 | 49.77 ± 13.46 |
Laboratory tests | |||
ESR (mm/h) ,Mean ± SD | 5.60 ± 2.11 | 15.01 ± 4.80 | 36.50 ± 8.22 |
CRP (mg/L), Mean ± SD | 6.25 ± 2.24 | 23.03 ± 4.76 | 65.85 ± 14.12 |
WBC (×109/L), Mean ± SD | 6.43 ± 1.28 | 8.72 ± 1.21 | 13.95 ± 1.65 |
HB (g/L), Mean ± SD | 132.95 ± 9.13 | 95.73 ± 9.58 | 70.60 ± 9.46 |
HCT (%), Mean ± SD | 40.17 ± 2.97 | 34.17 ± 2.84 | 29.29 ± 1.95 |
ALB (g/L), Mean ± SD | 47.77 ± 4.64 | 35.71 ± 2.81 | 28.45 ± 2.12 |